COVID-19 has inflicted the world for over two years. The recent mutant virus strains pose greater challenges to disease prevention and treatment. COVID-19 can cause acute respiratory distress syndrome (ARDS) and extrapulmonary injury. Dynamic monitoring of each patient's condition is necessary to timely tailor treatments, improve prognosis and reduce mortality. Point-of-care ultrasound (POCUS) is broadly used in patients with ARDS. POCUS is recommended to be performed regularly in COVID-19 patients for respiratory failure management. In this review, we summarized the ultrasound characteristics of COVID-19 patients, mainly focusing on lung ultrasound and echocardiography. Furthermore, we also provided the experience of using POCUS to manage COVID-19-related ARDS.
CITATION STYLE
Gao, X., Zou, X., Li, R., Shu, H., Yu, Y., Yang, X., & Shang, Y. (2022, December 1). Application of POCUS in patients with COVID-19 for acute respiratory distress syndrome management: a narrative review. BMC Pulmonary Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12890-022-01841-2
Mendeley helps you to discover research relevant for your work.